KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) FCF Margin (2016 - 2025)

Historic FCF Margin for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to 19.16%.

  • Boston Scientific's FCF Margin fell 66900.0% to 19.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 18.22%, marking a year-over-year increase of 24300.0%. This contributed to the annual value of 18.22% for FY2025, which is 24300.0% up from last year.
  • Latest data reveals that Boston Scientific reported FCF Margin of 19.16% as of Q4 2025, which was down 66900.0% from 22.94% recorded in Q3 2025.
  • Boston Scientific's 5-year FCF Margin high stood at 25.85% for Q4 2024, and its period low was 5.92% during Q1 2022.
  • Moreover, its 5-year median value for FCF Margin was 14.36% (2023), whereas its average is 12.77%.
  • Its FCF Margin has fluctuated over the past 5 years, first surged by 145500bps in 2021, then tumbled by -135100bps in 2022.
  • Over the past 5 years, Boston Scientific's FCF Margin (Quarter) stood at 6.78% in 2021, then skyrocketed by 171bps to 18.35% in 2022, then increased by 1bps to 18.52% in 2023, then surged by 40bps to 25.85% in 2024, then fell by -26bps to 19.16% in 2025.
  • Its FCF Margin was 19.16% in Q4 2025, compared to 22.94% in Q3 2025 and 22.31% in Q2 2025.